News and Press Releases
Press releases
Theralase Demonstrates 24 Month Stability of Lead Anti-Cancer Drug
Toronto, Ontario – September 18, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading ...
0Theralase Theralase Demonstrates Increased Efficacy for Latest Anti-Cancer Drug
Toronto, Ontario – September 12, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading ...
0Theralase Anti-Cancer Drugs Effective in the Destruction of Cervical Cancer
Toronto, Ontario – September 5, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading b...
0Theralase Increases Revenue 14% for 2Q 2017 Financial Statements
Toronto, Ontario – August 29, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading bio...
0Theralase Anti-Cancer Drugs Independently Verified and Validated
Toronto, Ontario – August 22, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading bio...
0Theralase Anti-Cancer Technology Effective for the Destruction of Lung Cancer
Toronto, Ontario – August 8, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biot...
0Theralase PDT Technology Used to Treat Fourth Patient for Bladder Cancer
Toronto, Ontario – August 1, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biot...
0Theralase Achieves Exploratory Endpoint of Efficacy for Anti-Cancer Technology
Toronto, Ontario – July 25, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biote...
0Theralase Releases Annual and Special Meeting Videos
Toronto, Ontario – July 5, 2017 Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a leading biot...
0Theralase Provides Clarification Regarding Certain Forward-Looking Statements
Toronto, Ontario – June 30, 2017 Further to its press releases dated November 1, 2016, May 1, 2017 and May 30, 2017, Theralase Technologies Inc...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.